• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

ProQuest Investments

edit

Founded in 1998, ProQuest Investments is a healthcare venture capital firm with over $875 million under management. We have 12 deal professionals and three offices, our headquarters in Princeton, and additional offices in San Diego and Montreal.

We invest in healthcare companies seeking financings ranging from seed to late-stage. Our portfolio reflects the rich diversity of the healthcare industry and exemplifies our commitment to fostering the growth of exceptional businesses. In addition to our breadth of experience across many sectors of the healthcare industry, we have special expertise in therapeutics, where innovations in drug discovery technologies and molecular analysis are transforming an enormous unmet medical need. With a proven superior track record and over 40 investments in such diverse therapeutic categories as oncology, pain and infectious disease, ProQuest Investments seeks to build long term, mutually beneficial partnerships with outstanding entrepreneurs.

At the end of 2006, ProQuest Investments closed its fourth fund of $425 million.

Milestones

edit

• 
  ProQuest Investments invested in Mevion Medical Systems. (1/24/12)
  Posted 1/24/12 at 7:51pm via mevion.com
• 
  ProQuest Investments invested in Telormedix. (1/10/12)
  Posted 1/10/12 at 8:12pm via businesswire.com
• 
  ProQuest Investments invested in Immune Design. (7/26/10)
  Posted 7/26/10 at 6:27pm via xconomy.com
• 
  ProQuest Investments invested in ReVision Optics. (7/20/10)
  Posted 7/21/10 at 5:08pm via onbiovc.com
• 
  ProQuest Investments invested in EUSA Pharma. (7/19/05)
  Posted 7/2/10 at 5:32am
• 
  ProQuest Investments invested in Mersana Therapeutics. (11/8/05)
  Posted 7/2/10 at 3:43am via mersana.com
• 
  ProQuest Investments invested in Predictive Biosciences. (6/18/10)
  Posted 6/20/10 at 3:45am via onbiovc.com
• 
  ProQuest Investments invested in Tragara. (4/15/10)
  Posted 4/15/10 at 7:38pm via onbiovc.com
• 
  ProQuest Investments invested in Excaliard Pharmaceuticals. (11/27/07)
  Posted 3/12/10 at 11:47pm via excaliard.com
• 
  ProQuest Investments invested in Gemin X Pharmaceuticals. (7/3/08)
  Posted 3/11/10 at 1:31am via siliconindia.com
• 
  ProQuest Investments invested in Gloucester Pharmaceuticals. (8/25/09)
  Posted 10/10/09 at 5:10am via gloucesterpharma.com
• 
  ProQuest Investments invested in Biosyntech. (8/14/09)
  Posted 9/29/09 at 6:43am via biosyntech.com
• 
  ProQuest Investments invested in Zosano Pharma. (8/6/09)
  Posted 8/6/09 at 10:23am via onbiovc.com
• 
  ProQuest Investments invested in LEAD Therapeutics. (11/5/07)
  Posted 7/15/09 at 2:25am via leadtherapeutics.com
• 
  ProQuest Investments invested in Zosano Pharma. (11/15/07)
  Posted 7/14/09 at 3:46am via zosanopharma.com
• 
  ProQuest Investments invested in Orthocon. (4/8/09)
  Posted 4/10/09 at 8:51am via pehub.com

Investments

Videos

Sources

1. Leading Private Venture Capital Firms Invest $45 Million in Mevion Medical Systems (mevion.com) [edit]
2. Telormedix Secures Further Funding (businesswire.com) [edit]
3. Immune Design Nabs $32M for Targeted Vaccines (xconomy.com) [edit]
4. ReVision Optics, Inc.: Series D $35M (onbiovc.com) [edit]
5. Predictive Biosciences, Inc.: Series C $25M (onbiovc.com) [edit]
6. Tragara Pharmaceuticals, Inc.: Series B $5M (onbiovc.com) [edit]
7. Gloucester Pharmaceuticals Completes $29 Million Financing (gloucesterpharma.com) [edit]
8. BioSyntech Announces $4.5 Million Financing (biosyntech.com) [edit]
9. Zosano Pharma, Inc.: Series B $30M (onbiovc.com) [edit]
10. Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development (onbiovc.com) [edit]
11. Orthocon Raises $25 Million (pehub.com) [edit]
12. Aerovance inhales $38M for asthma drugs (venturebeat.com) [edit]
13. Gemin X Pharmaceuticals closes $38 Mn Series C financing (siliconindia.com) [edit]
14. Excaliard closes $15.5 million Series A financing from Alta Partners, ProQuest Investments and RiverVest Venture Partners (excaliard.com) [edit]
15. Zosano Pharma, Inc. Announces Funding Close Totaling $90 Million (zosanopharma.com) [edit]
16. LEAD Therapeutics Raises $17 Million in Series A Financing (leadtherapeutics.com) [edit]
17. Mersana Therapeutics, Inc. Completes $21 Million Financing (mersana.com) [edit]
18. Cap Funding Report [edit]